Protein,Protein_definition,Disease_category,Disease,Method,Nb_SNP,OR[95%CI],P_value
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Chapter I Certain infectious and parasitic diseases,Candidiasis,Inverse variance weighted,31,1.00 [0.90-1.11],0.992527636532693
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Chapter I Certain infectious and parasitic diseases,Mycoses,Inverse variance weighted,31,1.03 [0.95-1.12],0.492774644715385
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,Inverse variance weighted,31,0.98 [0.95-1.02],0.313467923774917
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,Inverse variance weighted,31,1.00 [0.67-1.48],0.99101669077897
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Chapter I Certain infectious and parasitic diseases,Other septicaemia,Inverse variance weighted,31,1.01 [0.95-1.07],0.705465239308065
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,Inverse variance weighted,31,0.87 [0.52-1.45],0.587849958673739
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",Inverse variance weighted,31,1.01 [0.96-1.06],0.786673586983733
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",Inverse variance weighted,31,1.07 [1.01-1.14],0.033341960008484
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",Inverse variance weighted,31,1.03 [0.94-1.13],0.480608579108095
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",Inverse variance weighted,31,0.79 [0.66-0.96],0.0156632165433982
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Chapter X Diseases of the respiratory system,Early onset COPD,Inverse variance weighted,31,1.00 [0.90-1.12],0.928116659998026
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Chapter X Diseases of the respiratory system,Later onset COPD,Inverse variance weighted,31,0.98 [0.88-1.09],0.707051876948257
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,Inverse variance weighted,31,1.02 [0.96-1.07],0.582810084828013
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,Inverse variance weighted,31,0.87 [0.65-1.16],0.350544697506265
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",Inverse variance weighted,31,1.03 [0.96-1.11],0.422578943353723
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,Inverse variance weighted,31,0.91 [0.81-1.04],0.163312794862613
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,Inverse variance weighted,31,1.10 [0.93-1.29],0.283017866673535
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",Inverse variance weighted,31,0.98 [0.92-1.04],0.432857306919532
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,Inverse variance weighted,31,1.06 [0.95-1.18],0.290387050969976
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,Inverse variance weighted,31,0.97 [0.94-1.01],0.124346412834583
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,Inverse variance weighted,31,1.09 [0.95-1.26],0.20006430440703
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,Inverse variance weighted,31,0.91 [0.79-1.05],0.209271508445283
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,Inverse variance weighted,31,0.97 [0.89-1.04],0.378986140029531
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,Inverse variance weighted,31,1.06 [0.98-1.14],0.132289183102733
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,Inverse variance weighted,31,1.00 [0.95-1.06],0.95258986803194
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",Inverse variance weighted,31,0.99 [0.88-1.11],0.849136081542841
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,Inverse variance weighted,31,1.03 [1.00-1.07],0.0583680810409922
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,Inverse variance weighted,31,1.02 [0.99-1.06],0.252056885489607
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Chapter VI Diseases of the nervous system,Falls/tendency to fall,Inverse variance weighted,31,1.00 [0.98-1.03],0.728143769685521
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,Inverse variance weighted,31,1.00 [0.93-1.06],0.899169311204355
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",Inverse variance weighted,31,0.98 [0.92-1.04],0.481467650124044
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Chapter IX Diseases of the circulatory system,Conduction disorders,Inverse variance weighted,31,1.05 [0.99-1.13],0.116856107856383
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Chapter IX Diseases of the circulatory system,"Heart failure, strict",Inverse variance weighted,31,0.99 [0.95-1.03],0.617158532065249
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Chapter IX Diseases of the circulatory system,Hypotension,Inverse variance weighted,31,0.99 [0.90-1.10],0.916160972477921
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Chapter IX Diseases of the circulatory system,"Hypertension, essential",Inverse variance weighted,31,1.01 [0.98-1.04],0.571763880512641
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Chapter IX Diseases of the circulatory system,Hypertension,Inverse variance weighted,31,1.00 [0.97-1.04],0.784922258203331
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",Inverse variance weighted,31,1.11 [0.72-1.71],0.628864389856757
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,Inverse variance weighted,31,0.92 [0.87-0.97],0.0024706665747193
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,Inverse variance weighted,31,1.10 [0.93-1.31],0.276501269089204
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Chapter IX Diseases of the circulatory system,Secondary right heart disease,Inverse variance weighted,31,0.91 [0.75-1.10],0.315311948417031
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Chapter X Diseases of the respiratory system,Interstitial lung disease,Inverse variance weighted,31,0.99 [0.89-1.10],0.85938665773537
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,Inverse variance weighted,31,1.04 [0.89-1.22],0.593508844734785
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,Inverse variance weighted,31,1.00 [0.91-1.10],0.985651370398117
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",Inverse variance weighted,31,1.00 [0.96-1.04],0.989089334507205
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Chapter X Diseases of the respiratory system,Bronchiectasis,Inverse variance weighted,31,1.13 [0.99-1.29],0.0770344030393928
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Chapter X Diseases of the respiratory system,Emphysema,Inverse variance weighted,31,0.97 [0.82-1.14],0.707584184134202
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Chapter X Diseases of the respiratory system,Influenza and pneumonia,Inverse variance weighted,31,1.02 [0.99-1.05],0.231609658119296
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,Inverse variance weighted,31,1.00 [0.96-1.04],0.909472984583225
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,Inverse variance weighted,31,1.05 [0.99-1.11],0.115089518888862
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Chapter X Diseases of the respiratory system,Other diseases of pleura,Inverse variance weighted,31,0.92 [0.87-0.97],0.0024829325348787
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Chapter X Diseases of the respiratory system,Pleural effusion,Inverse variance weighted,31,0.85 [0.76-0.94],0.0017776120993755
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,Inverse variance weighted,31,1.07 [1.01-1.12],0.013035532253238
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",Inverse variance weighted,31,1.02 [0.99-1.06],0.218316656653131
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Chapter V Mental and behavioural disorders,Any mental disorder,Inverse variance weighted,31,1.01 [0.98-1.04],0.530546644556946
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",Inverse variance weighted,31,1.04 [0.99-1.10],0.126716898018123
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,Inverse variance weighted,31,1.01 [0.93-1.09],0.810161915109207
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,Inverse variance weighted,31,1.05 [0.89-1.24],0.558423521497222
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,Inverse variance weighted,31,0.99 [0.94-1.04],0.762024573020182
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,Inverse variance weighted,31,1.02 [0.98-1.07],0.281258639726741
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",Inverse variance weighted,31,0.98 [0.88-1.08],0.665025828629852
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,Inverse variance weighted,31,1.01 [0.96-1.05],0.825490136977374
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,Inverse variance weighted,31,1.05 [0.97-1.13],0.241435212728383
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,Inverse variance weighted,31,1.01 [0.96-1.07],0.578977583096774
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,Inverse variance weighted,31,1.06 [0.97-1.16],0.209913519784987
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,Inverse variance weighted,31,1.04 [1.00-1.08],0.0296214150055174
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Chapter XIV Diseases of the genitourinary system,Acute renal failure,Inverse variance weighted,31,1.04 [0.96-1.13],0.345991745349247
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,Inverse variance weighted,31,0.96 [0.79-1.17],0.717857151378079
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,Inverse variance weighted,31,1.04 [0.95-1.14],0.384771435942806
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,Inverse variance weighted,31,1.02 [0.99-1.06],0.227668549255164
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,Inverse variance weighted,31,1.00 [0.95-1.04],0.853783943634918
CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Chapter V Mental and behavioural disorders,Smoking dependency,Inverse variance weighted,31,0.96 [0.84-1.10],0.548035551291491
